Fabio
4.6 KiB
4.6 KiB
type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags
| type | title | description | jurisdiction | legislature | session | identifier | citation | classification | subjects | status | primary_sponsors | version_count | action_count | vote_count | first_action | last_action | source | source_identifier | source_url | source_hash | vintage | source_snapshot | retrieved_at | confidence | tags | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bill | AN ACT TO AMEND TITLE 18, TITLE 29, AND TITLE 31 OF THE DELAWARE CODE RELATING TO INSURANCE COVERAGE OF EPINEPHRINE AUTOINJECTORS. | This Act requires that individual, group, State employee, and public assistance insurance plans provide coverage for epinephrine autoinjectors for individuals who are 18 years of age or under and must include at least 1 formulation of epinephrine autoinjectors on the lowest tier of the drug formulary developed and maintained by the carrier if the insurance plan has tiers. | us/states/de | Delaware General Assembly | 151 | HB 95 | Delaware HB 95 (151) |
|
enacted |
|
1 | 9 | 2 | 2021-01-28 | 2021-06-15 | openstates | ocd-bill/7c14043f-7357-4637-9002-bb1d6ef643fe | https://legis.delaware.gov/BillDetail?LegislationId=48361 | c3f1507b1c06ef088ba8c81fcd45c034579411e28e3bd8cda8152b2ead742e9f | 2026-07-01 | https://data.openstates.org/daily/2026-07-01/public.pgdump | 2026-07-06 | reported |
|
Delaware HB 95 (151) — AN ACT TO AMEND TITLE 18, TITLE 29, AND TITLE 31 OF THE DELAWARE CODE RELATING TO INSURANCE COVERAGE OF EPINEPHRINE AUTOINJECTORS.
This Act requires that individual, group, State employee, and public assistance insurance plans provide coverage for epinephrine autoinjectors for individuals who are 18 years of age or under and must include at least 1 formulation of epinephrine autoinjectors on the lowest tier of the drug formulary developed and maintained by the carrier if the insurance plan has tiers.
Version chain
The bill's text revisions, in order — the diff chain from filing to enrollment.
- Bill Text (committee substitute) — source
Votes
- SM — 21–0 (pass) · upper
- SM — 40–0 (pass) · lower
Sponsors
- Andria L. Bennett — primary (person)
- John "Jack" Walsh — primary (person)
- Kimberly Williams — primary (person)
- Sarah McBride — primary (person)
- Brian Pettyjohn — cosponsor (person)
- Bryan Townsend — cosponsor (person)
- Bryant L. Richardson — cosponsor (person)
- David Bentz — cosponsor (person)
- David L. Wilson — cosponsor (person)
- David P. Sokola — cosponsor (person)
- Debra Heffernan — cosponsor (person)
- Edward S. Osienski — cosponsor (person)
- John A. Kowalko — cosponsor (person)
- Kendra Johnson — cosponsor (person)
- Krista Griffith — cosponsor (person)
- Larry Lambert — cosponsor (person)
- Marie Pinkney — cosponsor (person)
- Melissa Minor-Brown — cosponsor (person)
- Michael F. Smith — cosponsor (person)
- Michael Ramone — cosponsor (person)
- Nicole Poore — cosponsor (person)
- Paul S. Baumbach — cosponsor (person)
- Ruth Briggs King — cosponsor (person)
- S. Elizabeth Lockman — cosponsor (person)
- Sean M. Lynn — cosponsor (person)
- Sean Matthews — cosponsor (person)
- Sherry Dorsey Walker — cosponsor (person)
- Spiros Mantzavinos — cosponsor (person)
- Stephanie L. Hansen — cosponsor (person)
- Trey Paradee — cosponsor (person)
Timeline
The legislative action history — every referral, reading, and vote.
- 2021-01-28 Introduced and Assigned to Economic Development/Banking/Insurance & Commerce Committee in House
introduction, referral-committee - 2021-03-09 Reported Out of Committee (Economic Development/Banking/Insurance & Commerce) in House with 5 Favorable, 6 On Its Merits
committee-passage, committee-passage-favorable - 2021-03-19 Suspension of Rules in House
- 2021-03-19 Suspension of Rules in House
- 2021-03-25 Passed By House. Votes: 40 YES 1 ABSENT
passage - 2021-03-25 Assigned to Health & Social Services Committee in Senate
introduction, referral-committee - 2021-03-30 Reported Out of Committee (Health & Social Services) in Senate with 5 Favorable
committee-passage, committee-passage-favorable - 2021-03-31 Passed By Senate. Votes: 21 YES
passage - 2021-06-15 Signed by Governor
executive-signature
Source
OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/7c14043f-7357-4637-9002-bb1d6ef643fe. Confidence: reported (aggregated from official Delaware legislature records).